HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $25 price target.
Why Tharimmune Stock (THAR) Is Down 70% Today
Tharimmune Inc (NASDAQ: THAR) shares are trading lower by 71% to $1.00 Tuesday morning after the company priced an underwritten public offering of 10 million shares of common stock or pre-funded warrants at $1.00 per share, generating $10 million in
